Skip to main content
. 2023 Feb 17;102(7):e32956. doi: 10.1097/MD.0000000000032956

Table 1.

Clinical symptoms and long-term follow-up results of 6 patients with anti-GABABR encephalitis.

Assessment Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6
Sex M F F M M M
Age 76 66 49 56 70 74
Date to admitting 11 15 7 8 6 3
Previous history BPH and COPD No No No No BPH and COPD
Personal history Smoking No No Smoking Alcohol consumption No Smoking
Initial symptom Epilepsy Epilepsy Epilepsy Epilepsy Epilepsy Behavior disorder
Other symptom Memory deficit No Memory deficit Cognitive decline Behavior disorder Cognitive decline Behavior disorder Cognitive decline Status epilepticus Cognitive decline
CSF Pressure (mmH2O)* 123 108 158 162 150 250
Leukocyte in CSF 16 *106/L 17 *106/L 35 *106/L 56 *106/L 13 *106/L 15 *106/L
Protein in CSF 510 mg/L 840 mg/L 290 mg/L 480 mg/L 530 mg/L 550 mg/L
CSF antibody titer 1:100 1:32 1:320 1:32 1:32 1:32
Serum antibody titer 1:32 1:10 1:32 1:10 1:32 1:10
Other antibody in CSF or Serum Anti-Ma 2 antibody in Serum No No No No No
D-dimmer§ 1.1 mg/L 1.72 mg/L 0.51 mg/L 0.42 mg/L 0.31 mg/L 0.54 mg/L
Tumor maker No No No No No No
Tumors Suspected testicular cancer small cell cancer No small cell lung cancer Esophagus cancer No
Lesions on brain MRI Left frontal lobe, guide lobe, temporal lobe and hippocampus Bilateral guide lobe, frontal parietal lobe and basal ganglia No lesions Right hippocampus Bilateral hippocampus unchecked
EEG Normal Abnormal Abnormal Normal Normal Abnormal
Corticosteroid pulse therapy Yes Yes Yes Yes Yes Yes
IVIg No No No No Yes Yes
AEDs treatment in hospital VPA and LEV VPA and LEV VPA VPA and LEV LEV VPA and LEV
mRS score at admission 4 3 3 4 4 5
mRS score at discharge 1 2 0 0 4 6#
mRS score at 6 mo after onset 0 0 0 0 3 NA
Residual symptoms at discharge No No No No Cognitive decline NA
treatment after discharge Prednisone and LEV No No Prednisone and LEV Prednisone and LEV NA

AEDs = antiepileptic drug, anti-GABAB = Anti-gamma-aminobutyric acid B, BPH = benign prostatic hyperplasia, COPD = chronic obstructive pulmonary disease, CSF = cerebrospinal fluid, EEG = electroencephalography, IVIg = intravenous immunoglobulin, LEV = levetiracetam, MRI magnetic resonance imaging, mRS = modified Rankin scores, NA = not available, VPA = valproic acid.

*

normal range of CSF Pressure: 80-180 mmH2O,

normal range of CSF leukocyte count: 0-6 × 106/L,

normal range of CSF proteins: 150-450 mg/L,

§

normal range of D-dimmer: 0-0.55 mg/L FEU,

# death.